Principal Investigator
Justin Watts
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220142
Clinical Trial Summary
A Phase 1, Open-label, Dose Finding Study of CC-95251 Alone and in Combination with Antineoplastic Agents in Subjects with Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Leukemia
Contact Information
Phone Number
305-243-2647